DAVID POPLACK to Cell Survival
This is a "connection" page, showing publications DAVID POPLACK has written about Cell Survival.
Connection Strength
0.134
-
Desulfuration of 6-mercaptopurine. The basis for the paradoxical cytotoxicity of thiopurines in cultured human leukemic cells. Biochem Pharmacol. 1993 Nov 02; 46(9):1627-36.
Score: 0.023
-
Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts. Biochem Pharmacol. 1993 Apr 06; 45(7):1493-501.
Score: 0.022
-
Modulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridine. Cancer Res. 1992 Jun 15; 52(12):3503-5.
Score: 0.021
-
Intrathecal administration of 4-hydroperoxycyclophosphamide in rhesus monkeys. Cancer Res. 1987 Nov 15; 47(22):5932-4.
Score: 0.015
-
Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine. Cancer Res. 1986 Dec; 46(12 Pt 1):6286-9.
Score: 0.014
-
Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation. Cancer Res. 1985 Jan; 45(1):217-20.
Score: 0.013
-
Transplantation of leukemic bone marrow treated with cytotoxic antileukemic antibodies and complement. Science. 1982 Jul 16; 217(4556):259-61.
Score: 0.011
-
The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia. Leuk Res. 1994 Nov; 18(11):805-10.
Score: 0.006
-
An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys. Cancer Immunol Immunother. 1989; 28(1):59-66.
Score: 0.004
-
Probenecid inhibition of methotrexate cytotoxicity in mouse L1210 leukemia cells. Cancer Treat Rep. 1984 Mar; 68(3):521-5.
Score: 0.003